Clinical trials in Bojnice

Multiple clinical trials focusing on schizophrenia treatment are investigating new therapeutic approaches. Studies examine both long-term safety of novel compounds and the effectiveness of adjunctive treatments for patients with inadequate response to standard therapies.

• Schizophrenia treatment optimization
• Cognitive impairment research
• Antipsychotic augmentation studies

Additional research explores Major Depressive Disorder, testing new adjunctive therapies with existing antidepressants.

Innovative research in Type 2 Diabetes management is exploring combination therapies to optimize treatment outcomes. Studies focus on comparing new treatment approaches with traditional insulin therapy for overweight patients.

• Diabetes management optimization
• Weight management integration
• Insulin therapy alternatives

These trials aim to improve glycemic control while considering patient-specific factors.

Ground-breaking research targets cardiovascular disease prevention and treatment. Studies include evaluation of new treatments for atrial fibrillation and innovative approaches to preventing major adverse cardiovascular events.

• Primary ASCVD prevention
• Atrial fibrillation management
• Cardiovascular risk reduction

These trials focus on developing safer and more effective treatments for high-risk cardiac patients.